Victory Capital Management Inc Spero Therapeutics, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$7.27 - $14.18 $18,662 - $36,400	-2,567 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$5.27 - $10.41 $848 - $1,676	161 Added 6.69%	2,567 $21,000
Q4 2019 Feb 04, 2020	BUY	$9.46 - $12.16 $3,954 - $5,082	418 Added 21.03%	2,406 $22,000
Q3 2019 Nov 12, 2019	BUY	$9.01 - $12.55 $17,911 - $24,949	1,988 New	1,988 $21,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.